Hansen Pharmaceutical seeks to treat and prevent infections caused by antibiotic-resistant bacteria.
Hansen Pharmaceutical, LLC, is developing gaseous nitric oxide under pressure to improve patient quality of life by reducing infection rates and treating infections. By mitigating infection, Hansen hopes to lower the number of amputations and other serious medical procedures brought on by bacterial infection.
Diabetic foot complications, including infection, are a tremendous societal burden, costing more than $17 billion annually and leading to over 80,000 lower extremity amputations in the United States per year. More money is spent on diabetic foot complications than on breast cancer treatment in the US. Combined with rising rates of diabetes, aging populations, increased antibiotic resistance, and ever-growing health care costs, simply treating infections effectively has never been more critical.
Since spinning out the technology and intellectual property in 2017, Hansen is building on the groundbreaking work started at Barry University’s Paul & Margaret Brand Research Center at the School of Podiatric Medicine. Hansen’s core proprietary technology delivers gaseous nitric oxide under pressure (gNOp) to kill multi-drug resistant organisms such as MRSA, staphylococcus aureus, pseudomonas, and Acinetobacter baumannii. Hansen is developing the technology to drive nitric oxide into wounds to kill bacteria both on the surface and subcutaneously.
According to the World Health Organization, antibiotic resistance leads to longer hospital stays, higher medical costs, and increased mortality. This is such a significant issue that the WHO has established the Global Antibiotic Research and Development Partnership to develop and deliver new treatments or improve existing treatments by 2023. Hansen is positioned to address this need.
Company Details
- Address
- 7000 Sw 62nd Ave,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.hansenpharma.com
- Keywords
- wound care, nitric oxide, diabetic foot ulcers, podiatry, chronic wounds, gas under pressure, antibiotic resistance, infection.
- HQ
- South Miami, Florida
- Competitors
- Beckon Scientific, Jupiter, LD Technology, Llorens Pharmaceutical International Division Inc, Americhem Pharmaceutical Corp, Jiangsu Kanion Pharmaceutical Co., Ltd., Advanced Pharmaceutical Consultants, Inc.,, Biom Pharmaceutical Corporation, Florida Pharmaceutical Products, LLC, Biom Therapeutics.
Hansen Pharmaceutical, Llc Questions
Hansen Pharmaceutical, Llc's website is http://www.hansenpharma.com
Hansen Pharmaceutical, Llc's LinkedIn profile is https://www.linkedin.com/company/hansen-pharma
Hansen Pharmaceutical, Llc's industry is
Pharmaceutical Manufacturing
Hansen Pharmaceutical, Llc's top competitors are
Beckon Scientific,
Jupiter,
Ld Technology,
Llorens Pharmaceutical International Division Inc,
Americhem Pharmaceutical Corp,
Jiangsu Kanion Pharmaceutical Co., Ltd.,
Advanced Pharmaceutical Consultants, Inc.,,
Biom Pharmaceutical Corporation,
Florida Pharmaceutical Products, Llc,
Biom Therapeutics.
Hansen Pharmaceutical, Llc's categories are Pharmaceutical Manufacturing
